We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

102 hedge funds and large institutions have $68.6M invested in Precision BioSciences in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

294% more call options, than puts

Call options by funds: $63K | Put options by funds: $16K

35% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 26

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.42% less ownership

Funds ownership: 1.98% → 1.56% (-0.42%)

14% less funds holding

Funds holding: 119 → 102 (-17)

27% less capital invested

Capital invested by funds: $93.5M → $68.6M (-$24.9M)

57% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 28

Holders
102
Holders Change
-17
Holders Change %
-14.29%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
35
Reduced
26
Closed
28
Calls
$63K
Puts
$16K
Net Calls
+$47K
Net Calls Change
+$51K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$4.27M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2M
3
CA
CHI Advisors
New York
+$1.06M
4
JP Morgan Chase
JP Morgan Chase
New York
+$1.05M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$673K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$6.8M
2
GPP
Great Point Partners
Connecticut
-$4.82M
3
ACP
Acuta Capital Partners
California
-$3.28M
4
SCM
Sio Capital Management
New York
-$1.61M
5
HF
HRT Financial
New York
-$1.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tekla Capital Management
Massachusetts
$292K – – –
BCM
27
Bridgeway Capital Management
Texas
$288K +$351K +7,383 New
Federated Hermes
28
Federated Hermes
Pennsylvania
$261K -$428 -9 -0.1%
Goldman Sachs
29
Goldman Sachs
New York
$232K -$233K -4,903 -45%
XT
30
XTX Topco
Cayman Islands
$221K +$140K +2,941 +108%
State Street
31
State Street
Massachusetts
$216K – – –
CAPTRUST Financial Advisors
32
CAPTRUST Financial Advisors
North Carolina
$201K -$95 -2 -0%
AF
33
Allworth Financial
California
$186K – – –
Northern Trust
34
Northern Trust
Illinois
$183K +$38.9K +818 +21%
CSS
35
Cubist Systematic Strategies
Connecticut
$183K +$76K +1,600 +52%
VC
36
Vivo Capital
California
$182K – – –
CIC
37
Cornercap Investment Counsel
Georgia
$173K +$95.2K +2,003 +82%
Two Sigma Investments
38
Two Sigma Investments
New York
$165K +$182K +3,821 +948%
Man Group
39
Man Group
United Kingdom
$159K +$194K +4,075 New
Deutsche Bank
40
Deutsche Bank
Germany
$154K +$855 +18 +0.5%
Connor, Clark & Lunn Investment Management (CC&L)
41
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$152K +$23.2K +488 +14%
WMSA
42
Weiss Multi-Strategy Advisers
New York
$130K +$158K +3,333 New
PCM
43
Penserra Capital Management
California
$127K +$128K +2,692 +463%
Dimensional Fund Advisors
44
Dimensional Fund Advisors
Texas
$125K -$128K -2,686 -46%
OQS
45
Occudo Quantitative Strategies
Florida
$112K – – –
FCBT
46
First Citizens Bank & Trust
North Carolina
$111K – – –
HLA
47
Hamilton Lane Advisors
Pennsylvania
$103K – – –
Franklin Resources
48
Franklin Resources
California
$93K +$1.47K +31 +1%
SSA
49
Schonfeld Strategic Advisors
New York
$83K -$21K -442 -17%
HighTower Advisors
50
HighTower Advisors
Illinois
$81K +$37.2K +783 +60%
1
2
3 4 5

DTIL Hedge Fund Activity: Q3 2022 in Review

102 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2022, worth a combined $68.6M — down 27% from $93.5M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of DTIL and 12 opened new positions — a net loss of 16 holders — while 26 trimmed existing stakes and 35 added.

The largest buyer was Millennium Management, adding an estimated $4.27M. The largest seller was CVI Holdings, exiting entirely with an estimated $6.8M sold.

  • 102 institutional investors held Precision BioSciences (DTIL) as of Q3 2022, down from 119 in Q2 2022.
  • Funds reported $68.6M of Precision BioSciences stock for Q3 2022, down 27% quarter-over-quarter.
  • 12 funds opened new Precision BioSciences positions in Q3 2022 and 28 closed out, a net change of -16 holders.
  • The largest Precision BioSciences buyer in Q3 2022 was Millennium Management, an estimated $4.27M added.
  • The largest Precision BioSciences seller in Q3 2022 was CVI Holdings, an estimated $6.8M sold.

Based on aggregated 13F filings for Q3 2022.